HIGH-GRADE GLIOMA (WHO III-IV)
Clinical trials for HIGH-GRADE GLIOMA (WHO III-IV) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE GLIOMA (WHO III-IV) trials appear
Sign up with your email to follow new studies for HIGH-GRADE GLIOMA (WHO III-IV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young brain cancer patients: experimental drug combo enters trials
Disease control Not yet recruitingThis study tests whether adding a drug called ADI-PEG 20 to standard radiation and chemotherapy can help children, teens, and young adults with newly diagnosed high-grade glioma (a fast-growing brain tumor). About 97 participants will receive the combination therapy. The goal is …
Matched conditions: HIGH-GRADE GLIOMA (WHO III-IV)
Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 17, 2026 03:57 UTC
-
Glow-in-the-Dark dye could help surgeons spot and remove brain cancer
Diagnosis Not yet recruitingThis study tests a dye called FG001 that makes brain tumor tissue glow under a special light during surgery. The goal is to help surgeons see the difference between tumor and healthy tissue, so they can remove more of the cancer. About 76 adults with newly diagnosed high-grade gl…
Matched conditions: HIGH-GRADE GLIOMA (WHO III-IV)
Phase: PHASE2 • Sponsor: FluoGuide A/S • Aim: Diagnosis
Last updated Jun 15, 2026 18:57 UTC
-
Surgeons test High-Tech headset for better views in the operating room
Knowledge-focused Not yet recruitingThis study tests how well the MyVeo surgical headset shows surgical details during routine brain, spine, ear-nose-throat, or reconstructive surgeries. Surgeons will rate image quality, comfort, and safety while using the device. About 32 patients will take part, and no extra proc…
Matched conditions: HIGH-GRADE GLIOMA (WHO III-IV)
Sponsor: Leica Microsystems (Schweiz) AG • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:18 UTC